Teva Pharmaceutical Industries Ltd. (TEVA) beat market estimates on adjusted EPS for Q2 2018 while revenues came in line with expectations. Despite these results, the stock fell around 5% in … Continue reading Teva Pharmaceuticals shares take a tumble despite earnings beat